HEILONGJIANG, China, Sept. 4 /Xinhua-PRNewswire-FirstCall/ -- Yanglin Soybean, Inc. (OTC Bulletin Board: YSYB; "Yanglin Soybean" or "the Company"), a leading producer and processor of high-quality non-genetically modified (non-GM) soybean products in China, today announced that it has retained Grayling Global to lead a strategic communications program ("the IR program") to shareholders, the investment community and financial media.
As the investor relations counsel for Yanglin Soybean, Grayling Global will help raise the investment community’s awareness of the Company’s outstanding value and performance through timely corporate updates, direct communications with fund managers, financial media and investor conference presentations.
"We are pleased to have a global IR network and its senior counselors with rich experience of working with agricultural companies to help us raise our financial profile and ensure the investment community of the full understanding of our business model and exciting growth prospects," said Mr. Shulin Liu, Chief Executive Officer of Yanglin Soybean.
Grayling Global, a subsidiary of Huntsworth PLC (LSE: HNT), is headquartered in London, with offices in New York, Brussels, Bangkok, Singapore, Madrid, Moscow, Tel Aviv, Hong Kong, Istanbul, Los Angeles, Sacramento, Dublin, Edinburgh, Cardiff, Bristol, and Birmingham. The firm has over 200 consultants, focusing on first-class delivery in public affairs, public relations, investor relations and events management.
Mr. Liu also commented, "According to CCID Consulting, Chinese edible oil processing market posted nearly US$ 40 billion in sales in 2007 on a robust 38% year-over-year growth. Among all the edible oils consumed in the Chinese market, soybean oil is one of the most popular options due to its inexpensive price and balanced nutrition. According to MarketResearch.com, soybean oil processing industry in the US generated total revenue of approximately US$18 billion in 2007."
Yanglin Soybean’s manufacturing process includes sifting, crushing, heating and pressing soybeans, extracting and separating oil from crushed soybeans, and cleansing, hydrating and packaging of oil as well as drying and packaging soybean meal. Currently, the Company’s main products include soybean oil, salad oil and soybean meal. Yanglin Soybean plans to broaden its product line to include high-end products such as squeezed oil, powdered oil and proteins concentrate, textured protein and defatted soybean powder, while greatly enlarging the production capacity of salad oil. The Company has installed the equipment for manufacturing squeezed oil and expanded the production line for salad oil and has started production of these products at the end of 2007. The production facilities for powdered oil have been built and are now in trial production phase. Yanglin Soybean has also begun to build facilities for manufacturing soybean protein concentrates, textured protein and defatted soy powder, and these production lines will be put into operations by the end of 2008.
About Yanglin Soybean, Inc.
Yanglin Soybean, Inc. is a leading non-genetically modified (non-GM) soybean processor in China. The Company manufactures soybean oil, salad oil and soybean meal with an annual production capacity of 520,000 metric tons in 2008. The Company’s products are sold directly to its customers or through distributors. Majority of Yanglin Soybean’s customers are located in Northern China.
Safe Harbor Statement
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: Certain statements in this press release and oral statements made by the Company constitute forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. These statements include, without limitation, statements regarding our ability to prepare the company for growth, the Company’s planned capacity expansion in 2008 and predictions and guidance relating to the Company’s future financial performance. We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our financial condition, results of operations, business strategy and financial needs but they involve risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements, which may include, but are not limited to, such factors as unanticipated changes in product demand especially in the pharmaceutical industry, pricing and demand trends for the Company’s products, changes to government regulations, risk associated with operation of the Company’s new facilities, risk associated with large scale implementation of the company’s business plan, the ability to attract new customers, ability to increase its product’s applications, cost of raw materials, downturns in the Chinese economy, and other information detailed from time to time in the Company’s filings and future filings with the United States Securities and Exchange Commission. Investors are urged to consider these factors carefully in evaluating the forward-looking statements herein and are cautioned not to place undue reliance on such forward-looking statements, which are qualified in their entirety by this cautionary statement. The forward-looking statements made herein speak only as of the date of this press release and the Company undertakes no duty to update any forward-looking statement to conform the statement to actual results or changes in the company’s expectations.
For more information, please contact:
Yanglin Soybean, Inc.
Mr. Bode Xu
Chief Financial Officer
Email: yanglin_bodexu@hotmail.com
Grayling Global
Eddie Cheung
Investor Relations
Tel: +1-646-284-9414
Email: echeung@hfgcg.com
